{"prompt": "['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', '6.4.', 'Detailed description of study procedures', '6.4.1.', 'Procedures during the Screening Visit', '6.4.1.1.', 'Informed consent', 'The signed informed consent of the subject must be obtained before study participation', 'during the screening visit. Refer to Section 5.1 for the requirements on how to obtain', 'informed consent.', '6.4.1.2.', 'Check inclusion and exclusion criteria', 'All applicable inclusion and exclusion criteria as described in Sections 4.2 and 4.3 will be', 'checked before enrolment.', '6.4.1.3.', 'Record demographic data', 'Demographic data such as date of birth, gender, geographic ancestry will be recorded in', \"the subject's eCRF.\", '6.4.1.4.', 'Record medical history', \"The subject's medical history will be obtained by review of the subject's medical records.\", 'Prior to study participation, any pre-existing conditions or signs and/or symptoms present', 'in a subject will be recorded.', '6.4.1.5.', 'Record AECOPD history within the previous year', 'Documented, self-reported and non-documented AECOPD should be recorded in the', 'eCRF. However, for study participation the subject should have had at least one', 'documented moderate or severe AECOPD episode within the previous year.', '6.4.1.6.', 'Smoking exposure history (ATS-DLD-78A questionnaire)/biomass', 'exposure history (At screening visit only)', 'The subject will be asked to complete the smoking history questionnaire (which is a', 'shortened version of the American Thoracic Society-Division of Lung Diseases-78A', '[ATS-DLD-78A] questionnaire) by himself/herself. The subject will have to provide', 'information about his/ her smoking history, including duration (number of years) and', 'number of cigarettes smoked. Subject years exposed to biomass will be assessed from', 'information obtained on indoor exposure to fuels such as wood, crop waste and dung, or', 'coal.', 'From the information obtained via the questionnaire, calculation of the pack-years will be', 'done for inclusion into the study. Please refer to the SPM for details on how to calculate', 'pack years using this questionnaire and for guidance on administration of the exposure', 'history questionnaire.', '19-OCT-2018', '44', '75661ebdab2e949f7a1f1bc2071b9dec72acecci']['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', '6.4.1.7.', 'Smoking status', \"The subject's smoking status (current or former smoker) will be recorded in the eCRF.\", 'Refer to the glossary of terms for the definitions of current and former smoker.', '6.4.1.8.', 'Physical examination', 'At the screening visit, a complete physical examination of the subject will be performed', 'which will include vital signs after at least 10 minutes of rest (systolic/ diastolic blood', 'pressure, heart rate, respiratory rate). Collected information will be recorded in the eCRF.', 'Treatment of any abnormality observed during a physical examination has to be', 'performed according to local medical practice outside this study or by referral to an', 'appropriate health care provider.', '6.4.1.9.', 'Pregnancy test', 'Female subjects of childbearing potential are to have a urine pregnancy test prior to any', 'study procedure. Note: The urine pregnancy test must be performed even if the subject is', 'menstruating at the time of the study visit. The test should be carried out before', 'performing chest x-ray. If the test is positive, the chest X- ray should not be performed', 'and the subject should be withdrawn from the study.', '6.4.1.10. Measure/ record height and weight', \"The height and weight of the subject will be measured and recorded in the 'Physical\", \"examination' section of the eCRF.\", '6.4.1.11. Pre- and post-bronchodilator spirometry', 'Pre- and post-bronchodilator spirometry should be performed during the screening visit.', 'Only study-certified staff can perform spirometry assessment for this study. Spirometry', 'will be performed following the eResearch Technology (ERT) instructions for use', 'FlowScreen manual and following all safety requirements.', 'A good quality spirometry should be obtained, and will be confirmed by the spirometry', 'provider. If during the Screening Visit a good quality spirometry was not obtained, the', \"spirometry can be repeated, as per investigator's medical judgement. If a repeat\", 'spirometry is elected, the site should make all possible efforts to repeat the spirometry', 'preferably within 7 days of the previous spirometry. The data will be directly transferred', 'from the provider to GSK Biologicals.', 'Treatment of any abnormality observed during spirometry has to be performed according', 'to local medical practice outside this study or by referral to an appropriate health care', 'provider.', '19-OCT-2018', '45', '75661ebdab2e949f7a1f1bc2071b9dec72aceccf']\n\n###\n\n", "completion": "END"}